Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer

PURPOSE: Guidelines for locally advanced non-small cell lung cancer (LA-NSCLC) recommend definitive chemoradiation therapy (CRT) for cN2-N3 disease, reserving surgery for patients with minimal nodal involvement at presentation. The current literature suggests that surgery after CRT for stage III NSC...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Adv Radiat Oncol
Huvudupphovsmän: Vyfhuis, Melissa A.L., Bhooshan, Neha, Burrows, Whitney M., Turner, Michelle, Suntharalingam, Mohan, Donahue, James, Nichols, Elizabeth M., Feliciano, Josephine, Bentzen, Søren M., Badiyan, Shahed, Carr, Shamus R., Friedberg, Joseph, Simone, Charles B., Edelman, Martin J., Feigenberg, Steven J., Mohindra, Pranshu
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2017
Ämnen:
ROI Value of RT Publication Award Winner
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5605306/
https://ncbi.nlm.nih.gov/pubmed/29114590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.adro.2017.07.009
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk